Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - Stock Activity (Details)

v3.22.1
Stock-Based Compensation - Stock Activity (Details) - USD ($)
 12 Months Ended
Nov. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Number of Options        
Exercises (in shares) (2,424)      
Time-Vesting Options        
Number of Options        
Number of options granted (in shares)   561,897    
Equity Plan | Time-Vesting Options        
Number of Options        
Outstanding (in shares)   3,755,942    
Number of options granted (in shares)   229,194    
Exercises (in shares)   0    
Cancelled/ forfeited (in shares)   (224,817)    
Outstanding (in shares)   3,760,319    
Exercisable (in shares)   1,326,620 923,038 536,163
Vested and expected to vest, outstanding (in shares)   3,760,319    
Weighted Average Exercise Price        
Weighted average exercise price, outstanding (in usd per share)   $ 16.19    
Weighted average exercise price, grants (in usd per share)   18.32    
Weighted average exercise price, exercised (in usd per share)   0    
Weighted average exercise price, cancelled/ forfeited (in usd per share)   16.14    
Weighted average exercise price, outstanding (in usd per share)   16.32    
Weighted average exercise price, vested and exercisable (in usd per share)   16.10    
Weighted average exercise price, vested and expected to vest (in usd per share)   $ 16.32    
Weighted- Average Remaining Contractual Term (in years)        
Outstanding, weighted average remaining contractual term   6 years 10 months 6 days    
Vested and exercisable, weighted average remaining contractual term   6 years 5 months 23 days    
Vested and expected to vest, weighted average remaining contractual term   6 years 10 months 6 days    
Aggregate Intrinsic Value        
Outstanding, intrinsic value   $ 93,299 $ 1,900,000 $ 800,000
Vested and exercisable, intrinsic value   37,465    
Vested and expected to vest, intrinsic value   $ 93,299    
Omnibus incentive Plan        
Number of Options        
Outstanding (in shares)   0    
Number of options granted (in shares)   1,949,558    
Exercises (in shares)   0    
Cancelled/ forfeited (in shares)   (60,245)    
Outstanding (in shares)   1,889,313    
Exercisable (in shares)   0    
Vested and expected to vest, outstanding (in shares)   1,889,313    
Weighted Average Exercise Price        
Weighted average exercise price, outstanding (in usd per share)   $ 0    
Weighted average exercise price, grants (in usd per share)   19.00    
Weighted average exercise price, exercised (in usd per share)   0    
Weighted average exercise price, cancelled/ forfeited (in usd per share)   19.00    
Weighted average exercise price, outstanding (in usd per share)   19.00    
Weighted average exercise price, vested and exercisable (in usd per share)   0    
Weighted average exercise price, vested and expected to vest (in usd per share)   $ 19.00    
Weighted- Average Remaining Contractual Term (in years)        
Outstanding, weighted average remaining contractual term   9 years 9 months 25 days    
Vested and expected to vest, weighted average remaining contractual term   9 years 9 months 25 days    
Aggregate Intrinsic Value        
Outstanding, intrinsic value   $ 0    
Vested and exercisable, intrinsic value   0    
Vested and expected to vest, intrinsic value   $ 0